FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lalage Wakefield

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Lalage M Wakefield; Caroline S Hill
Beyond TGFβ: roles of other TGFβ superfamily members in cancer.
Christina Stuelten; Emily Sutton; Lalage M Wakefield; Joshua D Webster; Adrian Barbul; Johanna I Busch; Frances N Cervoni-Curet; Sandra L Kavalukas; John E Niederhuber
SDF-1α Mediates Wound-Promoted Tumor Growth in a Syngeneic Orthotopic Mouse Model of Breast Cancer.
Tsutomu Matsubara; Misako Sato; Naoki Tanaka; Lalage M Wakefield; Kazuo Ikeda; Dong Wook Kang; Kristopher W Krausz; Hans Luecke; Kathleen C Flanders; Frank J Gonzalez
TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lalage Wakefield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lalage M Wakefield; Caroline S Hill
Beyond TGFβ: roles of other TGFβ superfamily members in cancer.
Nature reviews. Cancer 2013;13(5):328-41.
2013: Christina Stuelten; Emily Sutton; Lalage M Wakefield; Joshua D Webster; Adrian Barbul; Johanna I Busch; Frances N Cervoni-Curet; Sandra L Kavalukas; John E Niederhuber
SDF-1α Mediates Wound-Promoted Tumor Growth in a Syngeneic Orthotopic Mouse Model of Breast Cancer.
PloS one 2013;8(4):e60919.
2012: Tsutomu Matsubara; Misako Sato; Naoki Tanaka; Lalage M Wakefield; Kazuo Ikeda; Dong Wook Kang; Kristopher W Krausz; Hans Luecke; Kathleen C Flanders; Frank J Gonzalez
TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.
Journal of lipid research 2012;53(12):2698-707.
2010: Arnulfo Mendoza; Sung-Hyeok Hong; Tanasa Osborne; Mohammed A Khan; Kirk Campbell; Joseph Briggs; Ananth Eleswarapu; Lauren Buquo; Ling Ren; Stephen M Hewitt; El Habib Dakir; El-H Dakir; Susan Garfield; Renard Walker; Glenn Merlino; Jeffrey E Green; Kent W Hunter; Lalage M Wakefield; Chand Khanna
Modeling metastasis biology and therapy in real time in the mouse lung.
The Journal of clinical investigation 2010;120(8):2979-88.
2010: Jonine D Figueroa; Kathleen C Flanders; Montserrat Garcia-Closas; William F Anderson; Xiaohong Rose Yang; Rayna K Matsuno; Máire A Duggan; Ruth M Pfeiffer; Akira Ooshima; Robert Cornelison; Gretchen L Gierach; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Lalage M Wakefield; Mark E Sherman
Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Breast cancer research and treatment 2010;121(3):727-35.
2010: Ran-Ju Kim; Soo-Rim Kim; Kyung-Jin Roh; Sang-Bum Park; Jeong-Ran Park; Kyung-Sun Kang; Gu Kong; Binwu Tang; Yu-An Yang; Ethan A Kohn; Lalage M Wakefield; Jeong-Seok Nam
Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer.
Cancer letters 2010;287(2):172-81.
2010: Ethan A Kohn; Misako Sato; Christina H Stuelten; Binwu Tang; Catherine M H Van Schyndle; Erwin P Bottinger; Zhijun Du; Wenjun Ju; Michael A Welsh; Yu-An Yang; Lalage M Wakefield
A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland.
Breast cancer research : BCR 2010;12(5):R83.
2010: Christina Stuelten; Johanna I Busch; Binwu Tang; Kathleen C Flanders; Akira Oshima; Emily Sutton; Tatiana S Karpova; Anita B Roberts; Lalage M Wakefield; John E Niederhuber
Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer.
PloS one 2010;5(3):e9832.
2010: Mitsutaka Kadota; Howard H Yang; Bianca Gomez; Misako Sato; Robert J Clifford; Daoud Meerzaman; Barbara K Dunn; Lalage M Wakefield; Maxwell P Lee
Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
PloS one 2010;5(2):e9201.
2009: Maria Giovanna di Bari; M E Christine Lutsiak; Shinji Takai; Sven Mostböck; Benedetto Farsaci; Roshanak Tolouei Semnani; Lalage M Wakefield; Jeffrey Schlom; Helen Sabzevari
TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression.
Cancer immunology, immunotherapy : CII 2009;58(11):1809-18.
2009: Mitsutaka Kadota; Misako Sato; Beverly Duncan; Akira Ooshima; Howard H Yang; Natacha Diaz-Meyer; Sheryl Gere; Shun-Ichiro Kageyama; Junya Fukuoka; Takuya Nagata; Kazuhiro Tsukada; Barbara K Dunn; Lalage M Wakefield; Maxwell P Lee
Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.
Cancer research 2009;69(18):7357-65.
2009: Hae-Young Park; Lalage M Wakefield; Mizuko Mamura
Regulation of tumor immune surveillance and tumor immune subversion by tgf-Beta.
Immune network 2009;9(4):122-6.
2009: Yansong Bian; Anita Terse; Juan Du; Bradford Hall; Alfredo A Molinolo; Pin Zhang; Wanjun Chen; Kathleen C Flanders; J Silvio Gutkind; Lalage M Wakefield; Ashok B Kulkarni
Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
Cancer research 2009;69(14):5918-26.
2009: Kathleen C Flanders; Lalage M Wakefield
Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.
Journal of mammary gland biology and neoplasia 2009;14(2):131-44.
2008: Christina Stuelten; Adrian Barbul; Johanna I Busch; Emily Sutton; Ryan David Katz; Misako Sato; Lalage M Wakefield; Anita B Roberts; John E Niederhuber
Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism.
Cancer research 2008;68(18):7278-82.
2008: Jeong-Seok Nam; Masaki Terabe; Mi-Jin Kang; Helen Chae; Nga Voong; Yu-An Yang; Arian Dominic John laurence; Aleksandra Michalowska; Mizuko Mamura; Scott Lonning; Jay A Berzofsky; Lalage M Wakefield
Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.
Cancer research 2008;68(10):3915-23.
2008: Jeong-Seok Nam; Masaki Terabe; Mizuko Mamura; Mi-Jin Kang; Helen Chae; Christina Stuelten; Ethan Kohn; Binwu Tang; Helen Sabzevari; Miriam R Anver; Scott Lawrence; David Danielpour; Scott Lonning; Jay A Berzofsky; Lalage M Wakefield
An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.
Cancer research 2008;68(10):3835-43.
2007: Jeong-Seok Nam; Setsuo Hirohashi; Lalage M Wakefield
Dysadherin: a new player in cancer progression.
Cancer letters 2007;255(2):161-9.
2007: Lalage M Wakefield; Christina Stuelten
Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis.
Cancer cell 2007;12(4):293-5.
2007: Binwu Tang; Naomi Yoo; Mary Vu; Mizuko Mamura; Jeong-Seok Nam; Akira Ooshima; Zhijun Du; Pierre-Yves Desprez; Miriam R Anver; Aleksandra M Michalowska; Joanna Shih; W Tony Parks; Lalage M Wakefield
Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.
Cancer research 2007;67(18):8643-52.
2007: Christina Stuelten; Anil K Kamaraju; Lalage M Wakefield; Anita B Roberts
Lentiviral reporter constructs for fluorescence tracking of the temporospatial pattern of Smad3 signaling.
BioTechniques 2007;43(3):289-90, 292, 294.
2007: Stefan Wildi; Jörg Kleeff; Julia Mayerle; Arthur Zimmermann; Erwin P Böttinger; Lalage M Wakefield; Markus W Büchler; Helmut Friess; Murray Korc
Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations.
Gut 2007;56(5):685-92.
2007: Lyuba Varticovski; Melinda G Hollingshead; Ana I Robles; Xiaolin Wu; James Cherry; David J Munroe; Luanne Lukes; Miriam R Anver; John P Carter; Suzanne D Borgel; Howard Stotler; Carrie A Bonomi; Nomeli P Nunez; Stephen D Hursting; Wenhui Qiao; Chuxia X Deng; Jeffrey E Green; Kent W Hunter; Glenn Merlino; Patricia S Steeg; Lalage M Wakefield; J Carl Barrett
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2168-77.
2006: Prem Seth; Zhen-Guo Wang; Amanda Pister; M Behzad Zafar; Sung Kim; Theresa Guise; Lalage M Wakefield
Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy.
Human gene therapy 2006;17(11):1152-60.
2006: Jeong-Seok Nam; Mi-Jin Kang; Adam M Suchar; Takeshi Shimamura; Ethan A Kohn; Aleksandra M Michalowska; V Craig Jordan; Setsuo Hirohashi; Lalage M Wakefield
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
Cancer research 2006;66(14):7176-84.
2006: Jeong-Seok Nam; Adam M Suchar; Mi-Jin Kang; Christina Stuelten; Binwu Tang; Aleksandra M Michalowska; Larry W Fisher; Neal S Fedarko; Alka Jain; Jan Pinkas; Scott Lonning; Lalage M Wakefield
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer.
Cancer research 2006;66(12):6327-35.
2006: Lalage M Wakefield; Kent Hunter
Introduction to breast disease review issue on metastasis.
Breast disease 2006;26():1-2.
2004: Mallika Kaviratne; Matthias Hesse; Mary Leusink; Allen W Cheever; Stephen J Davies; James H McKerrow; Lalage M Wakefield; John J Letterio; Thomas A Wynn
IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(6):4020-9.
2003: Fang Tian; Stacey DaCosta Byfield; W Tony Parks; Stephen Yoo; Angelina Felici; Binwu Tang; Ester Piek; Lalage M Wakefield; Anita B Roberts
Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Cancer research 2003;63(23):8284-92.
2003: Binwu Tang; Mary Vu; Timberly Booker; Steven J Santner; Fred R Miller; Miriam R Anver; Lalage M Wakefield
TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.
The Journal of clinical investigation 2003;112(7):1116-24.
2003: Ana I Nieto; Gopalan Shyamala; Jose J Galvez; Gudmundur Thordarson; Lalage M Wakefield; Robert Cardiff
Persistent mammary hyperplasia in FVB/N mice.
Comparative medicine 2003;53(4):433-8.
2003: Lalage M Wakefield; Gudmundur Thordarson; Ana I Nieto; Gopalan Shyamala; Jose J Galvez; Miriam R Anver; Robert Cardiff
Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling.
Comparative medicine 2003;53(4):424-32.
2003: Anita B Roberts; Lalage M Wakefield
The two faces of transforming growth factor beta in carcinogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(15):8621-3.
2002: Jeffrey E Green; Robert Cardiff; Lothar Hennighausen; Lalage M Wakefield; Ulrike Wagner; Eva Lee; Jeffrey Rosen; Daniel Medina; Alexander Nitkin; Edison Liu
Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM.
Transgenic research 2002;11(6):635-6.
2002: Donald Fraser; Lalage M Wakefield; Aled Phillips
Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor.
The American journal of pathology 2002;161(3):1039-49.
2002: Yu-An Yang; Oksana Dukhanina; Binwu Tang; Mizuko Mamura; John J Letterio; Jennifer MacGregor; Sejal C Patel; Shahram Khozin; Zi-Yao Liu; Jeffrey E Green; Miriam R Anver; Glenn Merlino; Lalage M Wakefield
Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.
The Journal of clinical investigation 2002;109(12):1607-15.
2002: Kenneth B Ewan; Gopalan Shyamala; Shraddha A Ravani; Yang Tang; Rosemary Akhurst; Lalage M Wakefield; Mary Helen Barcellos-Hoff
Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation.
The American journal of pathology 2002;160(6):2081-93.
2002: Tania Fernandez; Stephanie Amoroso; Shellyann Sharpe; Gary M Jones; Valery Bliskovski; Alexander L Kovalchuk; Lalage M Wakefield; Seong-Jin Kim; Michael Potter; John J Letterio
Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
The Journal of experimental medicine 2002;195(10):1247-55.
2002: Yu-An Yang; Binwu Tang; Gertraud Robinson; Lothar Hennighausen; Steven G Brodie; Chu-Xia Deng; Lalage M Wakefield
Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2002;13(3):123-30.
2002: Lalage M Wakefield; Anita B Roberts
TGF-beta signaling: positive and negative effects on tumorigenesis.
Current opinion in genetics & development 2002;12(1):22-9.
2001: K Morrisey; Rachel Anna Evans; Lalage M Wakefield; Aled O Phillips
Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin.
The American journal of pathology 2001;159(5):1905-15.
2001: I M McKenna; G Ramakrishna; Bhalchandra A Diwan; Y Kang; Yih-Horng Shiao; Lalage M Wakefield; D A Powell; L M Anderson; Sonia B Jakowlew
Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
Toxicology letters 2001;123(2-3):151-8.
2001: Lalage M Wakefield; Ester Piek; Erwin P Böttinger
TGF-beta signaling in mammary gland development and tumorigenesis.
Journal of mammary gland biology and neoplasia 2001;6(1):67-82.
2001: Jo Anne Zujewski; A Vaughn-Cooke; Kathleen C Flanders; Michael Eckhaus; Ronald A Lubet; Lalage M Wakefield
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.
Breast cancer research : BCR 2001;3(1):66-75.
2000: Yang Kang; Margaret A Prentice; Jennifer Mariano; S Davarya; R I Linnoila; Terry W Moody; Lalage M Wakefield; Sonia B Jakowlew
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Experimental lung research 2000;26(8):685-707.
2000: Yang Kang; Jennifer Mariano; Jerry Angdisen; Terry W Moody; Bhalchandra A Diwan; Lalage M Wakefield; Sonia B Jakowlew
Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
Molecular carcinogenesis 2000;29(2):112-26.
2000: Lalage M Wakefield; Yu-An Yang; O Dukhanina
Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models.
Breast cancer research : BCR 2000;2(2):100-6.
1999: Jo Anne Zujewski; L Pai; Lalage M Wakefield; Ruthann M Giusti; F A Dorr; C Flanders; R Caruso; M Kaiser; L Goodman; Maria Merino; M Gossard; M A Noone; Andrea M Denicoff; David Venzon; Kenneth H Cowan; Joyce A O'Shaughnessy
Tamoxifen and fenretinide in women with metastatic breast cancer.
Breast cancer research and treatment 1999;57(3):277-83.
1999: Binwu Tang; K de Castro; H E Barnes; W Tony Parks; LaMonica V Stewart; Erwin P Böttinger; David Danielpour; Lalage M Wakefield
Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Cancer research 1999;59(19):4834-42.
1998: Y Yang; ML Mumy; D Romeo; Lalage M Wakefield
Identification of the start sites for the 1.9- and 1.4-kb rat transforming growth factor-beta1 transcripts and their effect on translational efficiency.
Gene 1998;219(1-2):81-9.
1998: B Tang; Erwin P Böttinger; Sonia B Jakowlew; KM Bagnall; Jennifer Mariano; Miriam R Anver; John J Letterio; Lalage M Wakefield
Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.
Nature medicine 1998;4(7):802-7.
1998: R S Allison; ML Mumy; Lalage M Wakefield
Translational control elements in the major human transforming growth factor-beta 1 mRNA.
Growth factors (Chur, Switzerland) 1998;16(2):89-100.
1997: Erwin P Böttinger; John L Jakubczak; Diana C Haines; KM Bagnall; Lalage M Wakefield
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Cancer research 1997;57(24):5564-70.
1997: Erwin P Böttinger; John L Jakubczak; I S Roberts; ML Mumy; P Hemmati; KM Bagnall; Glenn Merlino; Lalage M Wakefield
Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
The EMBO journal 1997;16(10):2621-33.
1997: D Romeo; R S Allison; P Kondaiah; Lalage M Wakefield
Recharacterization of the start sites for the major human transforming growth factor-beta 1 mRNA.
Gene 1997;189(2):289-95.
1996: Erwin P Böttinger; Valentina M Factor; M L Tsang; J A Weatherbee; Jeffrey B Kopp; S W Qian; Lalage M Wakefield; Anita B Roberts; Snorri S Thorgeirsson; Michael B. Sporn
The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(12):5877-82.
1995: N Sanderson; Valentina M Factor; Péter Nagy; J Kopp; P Kondaiah; Lalage M Wakefield; Anita B Roberts; Michael B. Sporn; Snorri S Thorgeirsson
Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2572-6.
1995: Lalage M Wakefield; John J Letterio; T Chen; David Danielpour; R S Allison; L H Pai; A M Denicoff; MH Noone; Kenneth H Cowan; Joyce A O'Shaughnessy
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):129-36.
1995: Lalage M Wakefield; John J Letterio; A G Geiser; Kathleen C Flanders; Joyce A O'Shaughnessy; A B Roberts; Michael B. Sporn
Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters?
Progress in clinical and biological research 1995;391():133-48.
1994: Gianna Fiorelli; R Tracy Ballock; Lalage M Wakefield; Michael B. Sporn; F Gori; Laura Masi; U Frediani; Annalisa Tanini; Pietro Antonio Bernabei; Maria Luisa Brandi
Role for autocrine TGF-beta 1 in regulating differentiation of a human leukemic cell line toward osteoclast-like cells.
Journal of cellular physiology 1994;160(3):482-90.
1994: R Tracy Ballock; Ahlke Heydemann; Lalage M Wakefield; Kathleen C Flanders; Anita B Roberts; Michael B. Sporn
Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-beta.
Journal of cellular physiology 1994;159(2):340-6.
1993: R Tracy Ballock; Ahlke Heydemann; Lalage M Wakefield; Kathleen C Flanders; Anita B Roberts; Michael B. Sporn
TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases.
Developmental biology 1993;158(2):414-29.
1992: Seong-Jin Kim; K Park; David M Koeller; K Y Kim; Lalage M Wakefield; Michael B. Sporn; Anita B Roberts
Post-transcriptional regulation of the human transforming growth factor-beta 1 gene.
The Journal of biological chemistry 1992;267(19):13702-7.
1991: Lalage M Wakefield; P Kondaiah; R S Hollands; T S Winokur; Michael B. Sporn
Addition of a C-terminal extension sequence to transforming growth factor-beta 1 interferes with biosynthetic processing and abolishes biological activity.
Growth factors (Chur, Switzerland) 1991;5(3):243-53.
1990: Lalage M Wakefield; T S Winokur; R S Hollands; K Christopherson; A D Levinson; Michael B. Sporn
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.
The Journal of clinical investigation 1990;86(6):1976-84.
1990: P D Brown; Lalage M Wakefield; A D Levinson; Michael B. Sporn
Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3.
Growth factors (Chur, Switzerland) 1990;3(1):35-43.
1989: Lalage M Wakefield; D M Smith; S Broz; M Jackson; A D Levinson; Michael B. Sporn
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex.
Growth factors (Chur, Switzerland) 1989;1(3):203-18.
1989: Michael B. Sporn; Anita B Roberts; Lalage M Wakefield; A B Glick; David Danielpour
Transforming growth factor-beta and suppression of carcinogenesis.
Princess Takamatsu symposia 1989;20():259-66.
1988: Lalage M Wakefield; D M Smith; Kathleen C Flanders; Michael B. Sporn
Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.
The Journal of biological chemistry 1988;263(16):7646-54.
1988: Lalage M Wakefield; N L Thompson; Kathleen C Flanders; M D O'Connor-McCourt; Michael B. Sporn
Transforming growth factor-beta: multifunctional regulator of cell growth and phenotype.
Annals of the New York Academy of Sciences 1988;551():290-7; discussion 297-8.
1988: Anita B Roberts; Kathleen C Flanders; P Kondaiah; N L Thompson; E Van Obberghen-Schilling; Lalage M Wakefield; P Rossi; B de Crombrugghe; U Heine; Michael B. Sporn
Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis.
Recent progress in hormone research 1988;44():157-97.
1987: M D O'Connor-McCourt; Lalage M Wakefield
Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.
The Journal of biological chemistry 1987;262(29):14090-9.
1987: Michael B. Sporn; Anita B Roberts; Lalage M Wakefield; B de Crombrugghe
Some recent advances in the chemistry and biology of transforming growth factor-beta.
The Journal of cell biology 1987;105(3):1039-45.